Literature DB >> 21317158

Absence of disturbed axonal transport in spinal and bulbar muscular atrophy.

Bilal Malik1, Niranjanan Nirmalananthan, Lynsey G Bilsland, Albert R La Spada, Michael G Hanna, Giampietro Schiavo, Jean-Marc Gallo, Linda Greensmith.   

Abstract

Spinal and bulbar muscular atrophy (SBMA), or Kennedy's disease, is a late-onset motor neuron disease (MND) caused by an abnormal expansion of the CAG repeat in the androgen receptor (AR) gene on the X-chromosome, encoding a polyglutamine (poly-Q) sequence in the protein product. Mutant poly-Q-expanded AR protein is widely expressed but leads to selective lower motoneuron death. Although the mechanisms that underlie SBMA remain unclear, defective axonal transport has been implicated in MND and other forms of poly-Q disease. Transcriptional dysregulation may also be involved in poly-Q repeat pathology. We therefore examined axonal transport in a mouse model of SBMA recapitulating many aspects of the human disease. We found no difference in the expression levels of motor and the microtubule-associated protein tau, in the spinal cord and sciatic nerve of wild-type (WT) and SBMA mice at various stages of disease progression. Furthermore, we found no alteration in binding properties of motor proteins and tau to microtubules. Moreover, analysis of axonal transport rates both in cultured primary motoneurons in vitro and in vivo in the sciatic nerve of adult WT and mutant SBMA mice demonstrated no overt axonal transport deficits in these systems. Our results therefore indicate that unlike other motoneuron and poly-Q diseases, axonal transport deficits do not play a significant role in the pathogenesis of SBMA.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21317158      PMCID: PMC3071673          DOI: 10.1093/hmg/ddr061

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  51 in total

1.  Ligand promotes intranuclear inclusions in a novel cell model of spinal and bulbar muscular atrophy.

Authors:  Jessica L Walcott; Diane E Merry
Journal:  J Biol Chem       Date:  2002-10-17       Impact factor: 5.157

2.  Neuropathogenic forms of huntingtin and androgen receptor inhibit fast axonal transport.

Authors:  Györgyi Szebenyi; Gerardo A Morfini; Alyssa Babcock; Milena Gould; Kimberly Selkoe; David L Stenoien; Maureen Young; Pieter W Faber; Marcy E MacDonald; Michael J McPhaul; Scott T Brady
Journal:  Neuron       Date:  2003-09-25       Impact factor: 17.173

3.  Mutant dynactin in motor neuron disease.

Authors:  Imke Puls; Catherine Jonnakuty; Bernadette H LaMonte; Erika L F Holzbaur; Mariko Tokito; Eric Mann; Mary Kay Floeter; Kimberly Bidus; Dennis Drayna; Shin J Oh; Robert H Brown; Christy L Ludlow; Kenneth H Fischbeck
Journal:  Nat Genet       Date:  2003-03-10       Impact factor: 38.330

4.  Ligand-dependent aggregation of polyglutamine-expanded androgen receptor in neuronal cells.

Authors:  R Siobhan Darrington; Rachel Butler; P Nigel Leigh; Michael J McPhaul; Jean-Marc Gallo
Journal:  Neuroreport       Date:  2002-11-15       Impact factor: 1.837

5.  Androgen-dependent neurodegeneration by polyglutamine-expanded human androgen receptor in Drosophila.

Authors:  Ken-ichi Takeyama; Saya Ito; Ayako Yamamoto; Hiromu Tanimoto; Takashi Furutani; Hirotaka Kanuka; Masayuki Miura; Tetsuya Tabata; Shigeaki Kato
Journal:  Neuron       Date:  2002-08-29       Impact factor: 17.173

6.  Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy.

Authors:  Masahisa Katsuno; Hiroaki Adachi; Akito Kume; Mei Li; Yuji Nakagomi; Hisayoshi Niwa; Chen Sang; Yasushi Kobayashi; Manabu Doyu; Gen Sobue
Journal:  Neuron       Date:  2002-08-29       Impact factor: 17.173

7.  Mutations in dynein link motor neuron degeneration to defects in retrograde transport.

Authors:  Majid Hafezparast; Rainer Klocke; Christiana Ruhrberg; Andreas Marquardt; Azlina Ahmad-Annuar; Samantha Bowen; Giovanna Lalli; Abi S Witherden; Holger Hummerich; Sharon Nicholson; P Jeffrey Morgan; Ravi Oozageer; John V Priestley; Sharon Averill; Von R King; Simon Ball; Jo Peters; Takashi Toda; Ayumu Yamamoto; Yasushi Hiraoka; Martin Augustin; Dirk Korthaus; Sigrid Wattler; Philipp Wabnitz; Carmen Dickneite; Stefan Lampel; Florian Boehme; Gisela Peraus; Andreas Popp; Martina Rudelius; Juergen Schlegel; Helmut Fuchs; Martin Hrabe de Angelis; Giampietro Schiavo; David T Shima; Andreas P Russ; Gabriele Stumm; Joanne E Martin; Elizabeth M C Fisher
Journal:  Science       Date:  2003-05-02       Impact factor: 47.728

8.  Androgen receptor YAC transgenic mice recapitulate SBMA motor neuronopathy and implicate VEGF164 in the motor neuron degeneration.

Authors:  Bryce L Sopher; Patrick S Thomas; Michelle A LaFevre-Bernt; Ida E Holm; Scott A Wilke; Carol B Ware; Lee-Way Jin; Randell T Libby; Lisa M Ellerby; Albert R La Spada
Journal:  Neuron       Date:  2004-03-04       Impact factor: 17.173

9.  Disruption of axonal transport by loss of huntingtin or expression of pathogenic polyQ proteins in Drosophila.

Authors:  Shermali Gunawardena; Lu-Shiun Her; Richard G Brusch; Robert A Laymon; Ingrid R Niesman; Beth Gordesky-Gold; Louis Sintasath; Nancy M Bonini; Lawrence S B Goldstein
Journal:  Neuron       Date:  2003-09-25       Impact factor: 17.173

10.  Androgen receptor with elongated polyglutamine tract forms aggregates that alter axonal trafficking and mitochondrial distribution in motor neuronal processes.

Authors:  Federica Piccioni; Paolo Pinton; Silvia Simeoni; Paola Pozzi; Umberto Fascio; Guglielmo Vismara; Luciano Martini; Rosario Rizzuto; Angelo Poletti
Journal:  FASEB J       Date:  2002-07-18       Impact factor: 5.191

View more
  25 in total

1.  Impaired motoneuronal retrograde transport in two models of SBMA implicates two sites of androgen action.

Authors:  Michael Q Kemp; Jessica L Poort; Rehan M Baqri; Andrew P Lieberman; S Marc Breedlove; Kyle E Miller; Cynthia L Jordan
Journal:  Hum Mol Genet       Date:  2011-08-26       Impact factor: 6.150

Review 2.  Neurogenic and myogenic contributions to hereditary motor neuron disease.

Authors:  Katherine V Bricceno; Kenneth H Fischbeck; Barrington G Burnett
Journal:  Neurodegener Dis       Date:  2012-02-09       Impact factor: 2.977

Review 3.  The Role of the Protein Quality Control System in SBMA.

Authors:  Paola Rusmini; Valeria Crippa; Riccardo Cristofani; Carlo Rinaldi; Maria Elena Cicardi; Mariarita Galbiati; Serena Carra; Bilal Malik; Linda Greensmith; Angelo Poletti
Journal:  J Mol Neurosci       Date:  2015-11-14       Impact factor: 3.444

Review 4.  Targeted Molecular Therapies for SBMA.

Authors:  Carlo Rinaldi; Bilal Malik; Linda Greensmith
Journal:  J Mol Neurosci       Date:  2015-11-17       Impact factor: 3.444

Review 5.  Axonal transport deficits and neurodegenerative diseases.

Authors:  Stéphanie Millecamps; Jean-Pierre Julien
Journal:  Nat Rev Neurosci       Date:  2013-01-30       Impact factor: 34.870

6.  Global axonal transport rates are unaltered in htau mice in vivo.

Authors:  Aidong Yuan; Asok Kumar; Takahiro Sasaki; Karen Duff; Ralph A Nixon
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

Review 7.  Axonal transport and neurological disease.

Authors:  James N Sleigh; Alexander M Rossor; Alexander D Fellows; Andrew P Tosolini; Giampietro Schiavo
Journal:  Nat Rev Neurol       Date:  2019-09-26       Impact factor: 42.937

8.  Senataxin mutations elicit motor neuron degeneration phenotypes and yield TDP-43 mislocalization in ALS4 mice and human patients.

Authors:  Craig L Bennett; Somasish G Dastidar; Shuo-Chien Ling; Bilal Malik; Travis Ashe; Mandheer Wadhwa; Derek B Miller; Changwoo Lee; Matthew B Mitchell; Michael A van Es; Christopher Grunseich; Yingzhang Chen; Bryce L Sopher; Linda Greensmith; Don W Cleveland; Albert R La Spada
Journal:  Acta Neuropathol       Date:  2018-05-03       Impact factor: 17.088

9.  Co-induction of the heat shock response ameliorates disease progression in a mouse model of human spinal and bulbar muscular atrophy: implications for therapy.

Authors:  Bilal Malik; Niranjanan Nirmalananthan; Anna L Gray; Albert R La Spada; Michael G Hanna; Linda Greensmith
Journal:  Brain       Date:  2013-02-07       Impact factor: 13.501

10.  Mechanisms mediating spinal and bulbar muscular atrophy: investigations into polyglutamine-expanded androgen receptor function and dysfunction.

Authors:  Lenore K Beitel; Carlos Alvarado; Shaza Mokhtar; Miltiadis Paliouras; Mark Trifiro
Journal:  Front Neurol       Date:  2013-05-15       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.